Valo Health Appoints Chris Anagnostopoulos Chief Causal AI Officer

Valo Health appointed Chris Anagnostopoulos as Chief Causal AI Officer, a newly created role focused on advancing its human causal biology platform for drug discovery. The appointment was announced April 14 in a press release.

Anagnostopoulos will lead efforts to translate large-scale, real-world human data into causal insights that inform how drugs are discovered and developed. The role formalizes causal AI as a dedicated function within Valo’s platform.

Valo’s system is built on longitudinal datasets spanning more than 20 million patients, including records collected over 20 to 30 years with linked genomic data. The company uses machine learning to identify patient subtypes and applies causal inference techniques to determine the biological drivers of disease.

These insights feed into Valo’s predictive chemistry platform, where potential therapies are developed based on human-validated targets. The approach is designed to refine how diseases are classified and identify intervention points earlier in the discovery process.